Registered Members Login:
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

A reminder to all members that you agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.

Reply to this topic

PAR, Paradigm Pharmaceuticals
post Posted: Jan 22 2020, 04:11 AM
  Quote Post

Posts: 10,249
Thanks: 302

Is this the QRx reincarnation?

What did Uncle Mel do to us?
post Posted: Sep 27 2019, 10:02 AM
  Quote Post

Posts: 7,491
Thanks: 2546

Paradigm Biopharmaceuticals (PAR) $2.52

Another [pain relief aspirant] is the $394million market worth of Paradigm, which is seeking to repurpose an old deep-vein thrombosis drug for osteoarthritis pain. So far the compound, renamed Zilosul has worked wonders with the creaking knees and joints of ex-footballers including former Carlton great Greg Williams, while fellow Brownlow Medallist Chris Judd and ‘Leaping’ Leo Barry have invested in the company.

The drug is not approved and only available under a special access theme and is subject to two separate trials. “Real-world evidence” of 205 patients with knee osteoarthritis suggests pain reduction of more than 50 percent.

This month the company won US Food & Drug Administration assent to treat ten more patients under compassionate use status. The treating physician, Dr. John Michel is a former player with the National Football League club, the Green Bay Packers.

Given Paradigm shares have tripled in the last year and risen more than six-fold since listing four years ago, punters are warming to Paradigm’s anti-opioid shtick. If approved, and it’s a big if, Zilosul would be worth billions.
Tim Boreham

"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne

Back To Top Of Page
Reply to this topic

You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.